Lexitas

Lexitas

Ophthalmology-focused CRO for clinical trials

Overview

Lexitas Pharma Services is a clinical research organization focused exclusively on ophthalmology, helping biopharmaceutical and medical device companies advance eye-related products through clinical trials. It provides end-to-end ophthalmic trial services from strategy and protocol design to execution, data management, and analysis. Its niche focus lets it tailor study designs, imaging endpoints, regulatory considerations, and trial operations specifically for eye conditions, unlike generic CROs. Its goal is to help clients bring ophthalmic therapies and devices to market faster with high-quality data to support regulatory approvals and market access.

About Lexitas

Simplify's Rating
Why Lexitas is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Biotechnology

Healthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Durham, North Carolina

Founded

2011

Get referred to Lexitas

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • NAMSA partnership broadens ophthalmic device development opportunities.
  • Ocusun cataract study strengthens presence in non-surgical cataract development.
  • 170-plus trials and 700-plus sites support recurring sponsor wins.

What critics are saying

  • Single-therapeutic focus exposes Lexitas to ophthalmology sponsor churn.
  • Erie integration can disrupt imaging quality, sites, and margins.
  • Failed cataract efficacy would weaken demand for non-surgical ophthalmic programs.

What makes Lexitas unique

  • Exclusive ophthalmology CRO with 15 years of focused expertise.
  • Integrated reading center plus clinical operations across anterior and posterior segments.
  • Expanded retina platform after the May 2026 Erie acquisition.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Seeking Alpha
Feb 14th, 2024
Lexitas appoints Sriram Venkateswaran as CFO

Lexitas appoints Sriram Venkateswaran as CFO.

Global Advertising News
Sep 13th, 2023
Lexitas Pharma Services, Inc. Partners With DiagnosTear Ltd. For The Use Of TeaRx™ In Ophthalmic Clinical Trials

Lexitas Pharma Services, Inc. partners with DiagnosTear Ltd. for the use of TeaRx™ in ophthalmic clinical trials.

Recently Posted Jobs

Sign up to get curated job recommendations

Lexitas is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →